 These include blood and blood products, vaccines, allergenics, cell and tissue-based products, and gene therapy products.New biologics are required to go through a premarket approval process called a Biologics License Application (BLA), similar to that for drugs.The original authority for government regulation of biological products was established by the 1902 Biologics Control Act, with additional authority established by the 1944 Public Health Service Act.